Case Control Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Jul 26, 2022; 10(21): 7265-7274
Published online Jul 26, 2022. doi: 10.12998/wjcc.v10.i21.7265
Table 5 Distribution of modified Rankin scale scores in the two groups

Experimental group (n = 198)
Control group (n = 201)
Rank-sum test
P value
Baseline1.880.3903
No symptom15 (7.6)48 (23.6)
No significant disability132 (66.7)95 (47.8)
Mild disability38 (19.2)41 (20.2)
Moderate disability7 (3.5)9 (4.4)
Moderately severe disability6 (3.0)8 (3.9)
Severe disability00
Visit 1 (days 7 ± 2)11.661540.020
No symptom119 (60.1)89 (44.8)
No significant disability57 (28.8)86 (42.4)
Mild disability16 (8.1)17 (8.4)
Moderate disability6 (3.0)7 (3.4)
Moderately severe disability02 (1.0)
Severe disability00
Visit 2 (days 14 ± 2)6.0980.192
No symptom46 (55.4%)59 (41.8%)
No significant disability29 (34.9%)62 (44.0%)
Mild disability8 (9.6%)15 (10.6%)
Moderate disability04 (2.8%)
Moderately severe disability01 (0.7%)
Severe disability00